The Latest Breaking News from UNH

After UNH’s bruising 2025 collapse, can Evercore ISI’s “Outperform” call and turnaround thesis signal a timely entry point for investors willing to look past near-term scars?

The Nasdaq Composite, with a little help from tech's friends, rises to within 300 points of its own new all-time high.

After a bruising 2025 that sent shares to deep lows, is UnitedHealth up for a rebound as we enter the new year?

Trump’s call for health insurers to cut premiums adds political pressure to an already challenged sector, raising fresh questions about UnitedHealth’s pricing power, margins, and stock outlook heading into 2026.

UnitedHealth Group is poised to announce its fourth-quarter results next month, and analysts predict a double-digit decline in the company’s bottom-line figure.

UnitedHealth just announced it is expanding its pharmacy benefits model.

A Pennsylvania prison guard testified that Luigi Mangione, the man accused of murdering UnitedHealthcare (NYSE:UNH) CEO Brian Thompson, told him he had a 3D-printed gun in his backpack when police arrested him, adding a new wrinkle to a high-stakes fight over what evidence jurors will see.

UnitedHealth Group (NYSE:UNH) has reportedly reached a $1 billion agreement to sell its remaining South American operation, Banmedica, to Brazilian private equity firm Patria Investments.

Even though Cigna has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

UnitedHealth Group faces a pivotal upcoming deadline as Trump’s new healthcare plan, a DOJ probe, and commission cuts collide with solid revenue growth and a 2.7% dividend yield, forcing investors to weigh political risk against long-term strength.

Though UnitedHealth Group has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.